169 related articles for article (PubMed ID: 8795590)
1. How should cancer presenting as a malignant pleural effusion be managed?
Bonnefoi H; Smith IE
Br J Cancer; 1996 Sep; 74(5):832-5. PubMed ID: 8795590
[TBL] [Abstract][Full Text] [Related]
2. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of systemic chemotherapy in adenocarcinoma of the lung with pleuritis carcinomatosa].
Fujita A; Takabatake H; Tagaki S; Sekine K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1987-91. PubMed ID: 9350247
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support.
Fujita A; Takabatake H; Tagaki S; Sekine K
Chest; 2001 Feb; 119(2):340-3. PubMed ID: 11171707
[TBL] [Abstract][Full Text] [Related]
5. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
Kimura M; Tojo T; Naito H; Nagata Y; Kawai N; Taniguchi S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
[TBL] [Abstract][Full Text] [Related]
6. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
Tang Y; Xu L
J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
Rusch VW; Figlin R; Godwin D; Piantadosi S
J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Saijo N; Nishiwaki Y
J Thorac Oncol; 2008 Jul; 3(7):723-7. PubMed ID: 18594317
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer].
Gu LJ; Wang WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1023-6. PubMed ID: 16864104
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
13. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
Hickish TF; Smith IE; Nicolson MC; Ashley S; Priest K; Spencer L; Norman A; Middleton G; O'Brien ME
Br J Cancer; 1998 Jun; 77(11):1966-70. PubMed ID: 9667676
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
16. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
17. Advanced malignant lung disease: what the specialist can offer.
Gompelmann D; Eberhardt R; Herth FJ
Respiration; 2011; 82(2):111-23. PubMed ID: 21778793
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR
J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893
[TBL] [Abstract][Full Text] [Related]
19. Primary intrathoracic malignant effusion: a descriptive study.
Ang P; Tan EH; Leong SS; Koh L; Eng P; Agasthian T; Cheah FK
Chest; 2001 Jul; 120(1):50-4. PubMed ID: 11451815
[TBL] [Abstract][Full Text] [Related]
20. In lung cancer patients where a malignant pleural effusion is found at operation could resection ever still be justified?
Fiorelli A; Santini M
Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):407-12. PubMed ID: 23656925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]